Archive for the ‘ Medication Monitoring ’ Category

Ameritox Launches Critical, New Synthetic Marijuana Drug Test to Help Physicians Detect Rising Use of Dangerous Designer Drugs

October 26, 2012 / Ameritox

BALTIMORE. – October 3, 2012 – AmeritoxSM, the nation’s leader in medication monitoring solutions, today announced the launch of its newest test offering for synthetic cannabinoids (also known as “synthetic marijuana,” “K2,” or “Spice”), a class of designer drugs intended to mimic the effects of marijuana.  Adding to its portfolio of test offerings for designer drugs, which also includes a bath salts drug test (synthetic cathinones), Ameritox’s synthetic marijuana drug test now provides quantitative results for metabolites found in 15 synthetic cannabinoids that the Drug Enforcement Administration placed into Schedule I of the Controlled Substances Act this summer.